Hepatitis C - What is Hepatitis C?(NC)-Hepatitis C is an infectious virus that

What is Hepatitis C?

(NC)-Hepatitis C is an infectious virus that is carried in the blood and harms the liver. About 240,000 Canadians are infected, many of whom are unaware that they even have it. The number of people with hepatitis C is increasing in Canada and around the world, primarily among those who share needles and other drug equipment. An estimated 5,000 Canadians - mostly young people - get this virus each year. p>

Although the hepatitis C virus has been around for a long time, it was only identified in 1989. It causes inflammation of the liver, which often progresses to cirrhosis (scarring that makes it difficult for the liver to function normally). Of the estimated 5,000 people that are newly infected each year, up to 70 percent experience no symptoms. For some, symptoms may not show up for 20 or 30 years. In the meantime, they may, unknowingly, be infecting others. That is why it is important to know if you are at risk and how to take preventative action.

If you think you have hepatitis C, or that you may be at risk, visit your doctor and ask for the simple blood test for this disease. For more information, contact a health care professional, and visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.

Hepatitis C - Lamivudine does not increase the efficacy of interferon in the

Lamivudine does not increase the efficacy of interferon in the
hbv_research archives Lamivudine does not increase the efficacy of interferon in the treatment of mutant type chronic viral heaptitis B.

Lamivudine Journal Data
chronic Viral heaptitis B. Yang SS, Hsu CT, Hu JT, et al. World J Gastroenterol 2002 Oct;8(5):868-71 Abstract Remission of severe aplastic anemia associated

THE CONTRIBUTIONS OF NONHUMAN PRIMATE RESEARCH TO HUMAN HEALTH
Barker, LF, Maynard JE, Purcell RH, Hoofnagle JH, Berquist KR, London WT. 1975. Viral heaptitis, type B in experimental animals. Am J Med Sci 270:189-195.

Hepatitis C - Doctor: Getting the Most from Your Doctor s Appointment

Doctor: Getting the Most from Your Doctor s Appointment
Title: Doctor: Getting the Most from Your Doctor s Appointment
Category: Doctor's Views
Created: 5/13/2005
Last Editorial Review: 5/13/2005
Your Results May Vary For HCV Treatment
According to this study actual treatment results may be only half as good as touted. Doctors tend to trust the numbers presented by the pharaceutical companies. The pharma companies have a vested interest in presenting the best numbers they can...
Primary Biliary Cirrhosis
Title: Primary Biliary Cirrhosis
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 9/17/2005

Hepatitis C - Hepatitis C Virus Lives In Your Liver(NC)-Your liver works 24

Hepatitis C Virus Lives In Your Liver

(NC)-Your liver works 24 hours a day, performing over 500 vital functions for your body. Most of the blood that returns to your heart passes through the liver. Your body can't function without it.

The hepatitis C virus lives in your liver. It inflames liver cells, which, over time, affects the way your liver functions. The effect of the hepatitis C virus varies from person to person. There is no way to predict how your body will react to it. There are, however, some things that are known:

You can live with hepatitis C for many years without experiencing any major symptoms, or you might simply feel tired. Symptoms can come and go over time. Their presence or absence does not tell you the degree to which liver damage may or may not be occurring. p>

Chronic, long-term inflammation of the liver can cause liver cell damage and result in fibrosis (liver scarring), or even cirrhosis. This damage can occur in as little as five years, or as long as 30 years.

About 20% of chronic hepatitis patients develop cirrhosis within 10 to 20 years.

Use of recreational drugs or alcohol can speed up inflammation and the development of fibrosis or cirrhosis.

There is an increased risk of liver cancer in people with cirrhosis.

The good news is that current drug treatments can be very effective for people with hepatitis C. Combined with proper nutrition, plenty of rest, and avoidance of recreational drugs and alcohol, these treatments help many who have the virus lead relatively healthy lives.

If you think you may be at risk of getting hepatitis C, see your doctor. The virus can be detected by a simple blood test. For more information on how to keep your liver happy and healthy, visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

p>

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services. p>

Hepatitis C - MedlinePlus: Hepatitis C

MedlinePlus: Hepatitis C
features links to news and articles about HCV infection, its symptoms and diagnosis, treatment options, prevention, alternative therapies, and support organizations.

Advances in treatment of chronic hepatitis C: Pegylated' interferons (PDF)
... drug molecule are an important advance in the. treatment of chronic hepatitis C. ... more than 50% of cases of chronic hepatitis C. In contrast, ...

eMedicine - Hepatitis C : Article by Donald K Strickland, MD
... S, Petris MG, Rossetti F: Chronic hepatitis C virus infection after treatment for ... ribavirin as initial treatment for chronic hepatitis C: Hepatitis Interventional Therapy Group ...

HEPATITIS C
... by a healthcare professional familiar with chronic hepatitis C. Can you have a normal liver enzyme (e.g., ALT) level and still. have chronic hepatitis C? Yes ...

Chronic Hepatitis
Definition - Chronic Hepatitis (CAH) is ongoing injury to the cells of the liver with inflammation which lasts for longer than six months. ... Saharan Africa and among male homosexuals and IV drug users. Chronic hepatitis C behaves differently from hepatitis B ...

Hepatitis C - World J Gastroenterol

World J Gastroenterol
... Lamivudine does not increase the efficacy of interferon in the treatment of mutant type chronic viral heaptitis B. ...

hbv_research
... of interferon in the treatment of mutant type chronic viral heaptitis B. 23-Oct-2002 Hepatitis C and Hepatitis B Virus ...

Gastroenterology
... Clinicopathological study of viral heaptitis, A. ...

Giornale di malattie infettive e parassitarie on Medscape - 20 12
... of Owren's Thrombotest in acute viral hepatitis, viral heaptitis of prolonged duration, acute post-hepatitis atrophy of ...

Hepatitis C - Chronic Hepatitis C: Current Disease Management

Chronic Hepatitis C: Current Disease Management
Explains the causes and symptoms of hepatitis C, along with information about diagnosis and treatment.

HEPATITIS C INFO CENTER - With Daily Hepatitis C Updates
for decades before being discovered. According to the CDC, 20 to 30% of people with chronic Hepatitis C will eventually face life-threatening symptoms.

Hepatitis C - Hep C Bulletin

Hep C Bulletin
Almost 4 million Americans have been infected with the Hep C virus. I have been aware of a case that has literally turned the Adult Industry on its head lately about Hepatitis C. I am

Hepatitis C - Gastroenterology

Gastroenterology
... Clinicopathological study of viral heaptitis, A. ...

Hepatitis C - Hepatitis C

Hepatitis C
... Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration ...

Hepatitis C
Hepatitis c - resources for consumers. ... Hepatitis Foundation International. Viral Hepatitis C ...

Hepatitis C - HepHope.com

HepHope.com
... to stay on top of the latest news in the Hep C world. ... C: The BasicsSymptoms of Hep C. Ways Hep C Is SpreadWays Hep C Is ...

HCVets.com
provided by Veterans with hepatitis C to offer information about virus exposure methods during the Vietnam service era.

Hepatitis C - Ways You Can Get Infected With Hepatitis C(NC)-Hepatitis C is

Ways You Can Get Infected With Hepatitis C

(NC)-Hepatitis C is spread through contact with infected blood. Here are just some of the ways in which you can be infected with this virus:

Sharing needles, straws, pipes, spoons and other drug-related equipment.

(At least two-thirds of all new hepatitis C infections are drug-use related. Cleaning equipment with bleach does not always effectively kill the virus) p>

Getting a tattoo, body piercing or acupuncture from an operator who does not use sterile equipment or techniques

Being born to a mother with hepatitis C

Getting pierced by a needle or sharp equipment that has infected blood on it ( in a hospital, workplace situation, etc.) p>

People who had blood transfusions before the testing of blood donations became mandatory in 1990 may also be at risk. And, while the risk is low, it is also possible to become infected by sharing personal household articles such as a razor or toothbrush with an infected person. The risk of transmission of hepatitis C during sex is also low, unless both parties have open bleeding sores.

It is estimated that 240, 000 people in Canada are currently infected with hepatitis C, of whom only 30% know they have the virus.

If you think you may be at risk, either now or from past risky activities see a doctor. The virus can be detected with a simple blood test, and there are steps and medications you can take to successfully minimize the effects of the disease if your diagnosis is positive. For more information, visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.

Hepatitis C - Vaccination Tames Hepatitis A Infection

Vaccination Tames Hepatitis A Infection
Title: Vaccination Tames Hepatitis A Infection
Category: Health News
Created: 7/13/2005 1:58:00 AM
Last Editorial Review: 7/13/2005 1:58:14 AM
More HCV Treatment News Coverage
The Los Angeles Times is one of the largest daily newspapers in the US. Their interest in HCV is indicative of a growning awareness of the extent of the disease in this country. The article clearly focuses on the hope...
Magnetic Resonance Imaging (MRI Scan)
Title: Magnetic Resonance Imaging (MRI Scan)
Category: Procedures and Tests
Created: 12/31/1997
Last Editorial Review: 8/31/2005
Judge denies new trial in hepatitis C case
Blink: Hepatitis C Bio, Pics, News and Views from BlinkBits
Subject: Judge denies new trial in hepatitis C case
Added by mfeed on Dec 01, 2005 10:36 am (GMT -4)

Sioux City Journal - Judge denies new trial in hepatitis C case FREMONT, Neb. ( AP) -- A doctor and nurse accused of infecting 99 patients with hepatitis C will not receive a new trial.Dodge County District Judge John Samson denied a motion filed by attorneys for Dr.... Read more...

Original Bit Published: 01 Dec 05 00:00:00 PST

Hepatitis C - Treating Chronic Mutational Hepatitis B with Chinese Medicine Vitalliver (Vigconic

Treating Chronic Mutational Hepatitis B with Chinese Medicine Vitalliver (Vigconic Suppositories)

Treating chronic mutational hepatitis B with Chinese medicine Vitalliver (Vigconic suppositories)

ZHANG GUAN HUA, LIANG CHAO, ZHENG WAN PIN

Chengdu University of TCM, Hepatitis Laboratory in the attached hospital of Chengdu University of TCM, Sichuan, China

Research Method:

Quantitative determination by contrasting HBV-DNA of cases before and after the treatment.

Number of cases: 25 (n)

Case Selection: Between the age of 16 and 65, in accordance with the diagnosis standards pf chronic Hepatitis B, with negative e antigen and positive e antibody, HBV-DNA > 1 104 cp/mL.

Detection Method: All the blood samples are detected by Sichuan Clinical Detection Center; PCR-ELISA quantitative determination is used within detection range of 1 104 - 1 107-8, HBV-DNA, unit of measurement is cp/mL.

Direction Plan: one suppository provided by Vigconic (International) Ltd. Bid. The course of treatment is six months, the tracing observation after withdrawal lasts six months.

Observation index:

1. HBV-DNA response after the treatment.
   

2. Lasting HBV-DNA response (six months after withdrawal).
   p>

Criterion of Therapeutic Effect:

1. If HBV-DNA volume 1 104 cp/mL: 4/25 (16%)
   

2. Lasting response:
   

HBV-DNA volume 1 104 cp/mL: 2/25 (8%)

Among the results of lasting response, 16 blood serum samples are detected through fluorimetric quantitative determination PCR by the instruments of PE.USD, H-7700 in the second attached hospital of Guangzhou Medical College. The result is in accordance with that in Sichuan Clinical Testing Center. (8 cases among it 1 102 cp/mL). The testing range of this testing method is 1 102 - 1 107-8 cp/mL.

Conclusion

The reason for the repeatedly abnormal liver function of Chronic Hepatitis B (CHB) patients lies in the repeatedly duplication of HBV after infection, which leads to fibrosis of liver, then cirrhosis and liver cancer. It is commonly accepted that if CHB shows the transformation of HBeAg/Anti-HBe, HBV-DNA becoming negative, liver function returning to normal state, the disease is relieved. However, parts of patients with the transformation of HBeAg/Anti-HBe still remain positive in HBV-DNA and the pathological change in the liver continues. Because HBV-DNA occurs promoter mutation in the anterior C section (1896 necleoside G-A variation) or in the C section (1762 nucleoside T variation, 1764 G-A variation), HBeAg cannot come into being. Therefore, the HBeAg in the patient s blood cannot be detected, while the virus can keep on duplicating and fixing itself. Through sequential assay of nucleic acid, it proves that promoter mutation appears in 30%-60% of HBeAg negative Chronic Hepatitis B (CHB) in the anterior C section or in the C section. In some provinces and cities of the People of China, the percentage of promoter mutation appears in HBeAg negative Chronic Hepatitis B (CHB) in the anterior C section or in the C section is from 17.6% to 78.9%. Eight out of the 25 cases of our observation go through the sequential assay of nucleic acid carried out by the Department of Microbiology of the University of Hong Kong. It all proves to have HBV-DNA mutation. The chronic mutational Hepatitis B is infectious and apt to cause cirrhosis and liver cancer since the present medicines of antivirus and immuno-modulator do not produce the expected therapeutic effects.

Vitalliver suppository is made up from a formula of Chinese herbs, including Ginseng, Deer Horn, Cordyceps, Radix Astragali, Frudctus Cnidii, Semen Cuscutae, etc. The formula is mainly for strengthening the body resistant and primarily for reinforcing Kidney Qi, which produces good therapeutic effects in treating chronic mutational Hepatitis B. The mechanism is probably that through the regulating of immune system, the duplication of virus is inhibited and meanwhile the liver is protected, so it can produce a lasting therapeutic effect. No adverse reaction and severe accident happens during clinical observation, so it is safe for using. Vitalliver is bringing hopes to the treatment of chronic mutational Hepatitis B.

* The second stage of clinical trial would be carrying out by the Microbiology Department of the University of Hong Kong and Chengdu University of Traditional Chinese Medicine.

For more information, please visit: http://www.vigconic.com

Or, contact:

William Yip cs@vigconic.com
p>
5/F, Cheung Wah Building, Sheung Heung Rd,

Kowloon, Hong Kong

Tel: 852-27656200

Fax: 852-27645314
p>

Chengdu University of TCM, Hepatitis Laboratory in the attached hospital of Chengdu University of TCM, Sichuan, China

webmaster@vigconic.com

Hepatitis C - Hepatitis C Solutions ::: Alternative Hepatitis C treatment

Hepatitis C Solutions ::: Alternative Hepatitis C treatment
Hepatitis C is controllable, Hepatitis C can be beat. Welcome to your Hep C Solution. A recent study showed that 65% of veterans using a San

Hepatitis C: FAQ | CDC Viral Hepatitis
trials (research studies), see www.clinicaltrials.gov . Roche has a Hep C Action Newsletter including details about hepatitis C treatments and services see

Hep C Discussion TOC
Hormones, menopause and Hep C - Yikes! Sharon 7/11/2005 Re: Hormones, menopause and Hep C - Yikes! rlb 7/11/2005 Who Would be Interestd In . Wanda 7/11/2005 Re: Who Would be Interestd

Hep-C
the general population has Hep C, CDoC has done studies that show that 54% of the women and 39% of the men entering prison in California have had an infection with Hep C. The Hep C epidemic has hit

Hepatitis C - Is There A Vaccine For Hepatitis C?(NC)-No, not for hepatitis

Is There A Vaccine For Hepatitis C?

(NC)-No, not for hepatitis C. There are vaccines for hepatitis A and hepatitis B. To prevent further damage to your liver, your doctor may advise you to be vaccinated against hepatitis A and hepatitis B.

Could I give hepatitis C to someone else?

Yes, as far as we know, once you have hepatitis C, you can always transmit it to someone else if they come in contact with your blood. If you have hepatitis C, you can't donate blood. You should avoid sharing personal items like razors and toothbrushes, because the virus is spread through blood to blood contact.

Although the virus isn't spread easily by sexual contact or from a mother to her unborn baby, the risk of transmitting the virus is not absent. Therefore, talk to your doctor first if you want to have children. p>

For more information on hepatitis C visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.

Hepatitis C - National HCV Prison Coalition - Hepatitis C Awareness Project

National HCV Prison Coalition - Hepatitis C Awareness Project
The National Hepatitis C Prison Coalition provides support to prison inmates who are suffering from hepatitis C (HCV) and HIV/HCV coinfection.

HCV Advocate Newsletter
The HCV Advocate newsletter is a valuable resource designed to provide the hepatitis C community with monthly updates on events, clinical research,

Genotyping - HCV News Articles
HIVandHepatitis.com: The Internet publication with accurate, timely and cutting-edge information on treatment and experimental vaccines for Hepatitis C.

HCV Advocate.org
New First Steps with HCV — for the Newly Diagnosed Click on "HCV Advocate" in the top left corner to return to home at any time.

HCV
hepatitis C virus (HCV) was first definitively identified by molecular cloning of The HCV genome consists of a positive-sense RNA molecule approximately

Hepatitis C - HepNet - Hepatitis Update 1:How Significant is Hepatitis C Infection

HepNet - Hepatitis Update 1:How Significant is Hepatitis C Infection
Would you like to see the complete index ? Update 1 - Fall 1995 How significant is hepatitis C infection in Canada? Dr. Sherman is a Hepatologist practicing in Toronto, Canada. This paper has been

"Many Infants Acquire Hepatitis C Infection from Infected Mothers in
Many Infants Acquire Hepatitis C Infection from Infected Mothers in Utero" "Many Infants Acquire Hepatitis C Infection from Infected Mothers in Utero" Women's Health Weekly (09.01.05) Many

hepCuk.info
of the UK National Health Service (NHS), EASL 2004 3. Parkes J. Epidemiology of Hepatitis C infection. Presentation at EASL, April 2005. 4. Health Protection Agency. Hepatitis C laboratory

Hepatitis C - Hepatitis C

Hepatitis C
Title: Hepatitis C
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 9/17/2005
Your Results May Vary For HCV Treatment
According to this study actual treatment results may be only half as good as touted. Doctors tend to trust the numbers presented by the pharaceutical companies. The pharma companies have a vested interest in presenting the best numbers they can...
Hepatitis C
Title: Hepatitis C
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 9/17/2005
Hepatitis C Caring Ambassadors Program Joins High School Students' Rally on Capi
Blink: Hepatitis C Bio, Pics, News and Views from BlinkBits
Subject: Hepatitis C Caring Ambassadors Program Joins High School Students' Rally on Capi
Added by mfeed on Dec 01, 2005 10:36 am (GMT -4)

Market Wire - OREGON CITY, OR -- (MARKET WIRE) -- 12/01/2005 -- At Robinson Secondary School in Fairfax, Virginia, the students in the marketing association (DECA) are working diligently to change of the outcome of the hepatitis C epidemic. ... change of the outcome of the hepatitis C epidemic. In an ongoing effort supported by the Hepatitis C Caring Ambassadors Program (HCCAP), the ...... Read more...

Original Bit Published: 01 Dec 05 00:00:00 PST

Hepatitis C - MIGENIX Inc. (MGI.TO) Second Quarter Fiscal 2006 Financial Results Conference Call & Web Cast Notification

MIGENIX Inc. (MGI.TO) Second Quarter Fiscal 2006 Financial Results Conference Call & Web Cast Notification
BioSpace - include drug candidates for the treatment of chronic Hepatitis C infections (Phase II), the prevention of catheter

Schering-Plough's Oral HCV Protease Inhibitor Demonstrates Potent Antiviral Activity as Monotherapy and in Com
Canada NewsWire - Results Reported at American Association for the Study of Liver Diseases (AASLD) Meeting Large Phase II Combination Study Under Way SAN FRANCISCO, Nov. representing an area of great unmetmedical need. Chronic hepatitis C affects more than 10 million people inmajor world

MIGENIX Initiates Enrollment in Phase IIb Hepatitis C Clinical Study of Celgosivir
BC Technology - glucosidase 1 inhibitor, in development for the treatment of chronic hepatitis C virus infections the success of treatment for patients suffering from chronic hepatitis C infections

Biolex Therapeutics Announces Initiation of Phase 1 Clinical Study of Hepatitis C Candidate Locteron(TM)
Drug News Wire - for the treatment of patients with chronic hepatitis C. Locteron combines BLX-883, a standard treatment for patients with chronic hepatitis C is pegylated alfa interferon

Hepatitis C - Is There A Vaccine For Hepatitis C?(NC)-No, not for hepatitis

Is There A Vaccine For Hepatitis C?

(NC)-No, not for hepatitis C. There are vaccines for hepatitis A and hepatitis B. To prevent further damage to your liver, your doctor may advise you to be vaccinated against hepatitis A and hepatitis B.

Could I give hepatitis C to someone else?

Yes, as far as we know, once you have hepatitis C, you can always transmit it to someone else if they come in contact with your blood. If you have hepatitis C, you can't donate blood. You should avoid sharing personal items like razors and toothbrushes, because the virus is spread through blood to blood contact.

Although the virus isn't spread easily by sexual contact or from a mother to her unborn baby, the risk of transmitting the virus is not absent. Therefore, talk to your doctor first if you want to have children. p>

For more information on hepatitis C visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.

Hepatitis C - Treating Chronic Mutational Hepatitis B with Chinese Medicine Vitalliver (Vigconic

Treating Chronic Mutational Hepatitis B with Chinese Medicine Vitalliver (Vigconic Suppositories)

Treating chronic mutational hepatitis B with Chinese medicine Vitalliver (Vigconic suppositories)

ZHANG GUAN HUA, LIANG CHAO, ZHENG WAN PIN

Chengdu University of TCM, Hepatitis Laboratory in the attached hospital of Chengdu University of TCM, Sichuan, China

Research Method:

Quantitative determination by contrasting HBV-DNA of cases before and after the treatment.

Number of cases: 25 (n)

Case Selection: Between the age of 16 and 65, in accordance with the diagnosis standards pf chronic Hepatitis B, with negative e antigen and positive e antibody, HBV-DNA > 1 104 cp/mL.

Detection Method: All the blood samples are detected by Sichuan Clinical Detection Center; PCR-ELISA quantitative determination is used within detection range of 1 104 - 1 107-8, HBV-DNA, unit of measurement is cp/mL.

Direction Plan: one suppository provided by Vigconic (International) Ltd. Bid. The course of treatment is six months, the tracing observation after withdrawal lasts six months.

Observation index:

1. HBV-DNA response after the treatment.
   

2. Lasting HBV-DNA response (six months after withdrawal).
   p>

Criterion of Therapeutic Effect:

1. If HBV-DNA volume 1 104 cp/mL: 4/25 (16%)
   

2. Lasting response:
   

HBV-DNA volume 1 104 cp/mL: 2/25 (8%)

Among the results of lasting response, 16 blood serum samples are detected through fluorimetric quantitative determination PCR by the instruments of PE.USD, H-7700 in the second attached hospital of Guangzhou Medical College. The result is in accordance with that in Sichuan Clinical Testing Center. (8 cases among it 1 102 cp/mL). The testing range of this testing method is 1 102 - 1 107-8 cp/mL.

Conclusion

The reason for the repeatedly abnormal liver function of Chronic Hepatitis B (CHB) patients lies in the repeatedly duplication of HBV after infection, which leads to fibrosis of liver, then cirrhosis and liver cancer. It is commonly accepted that if CHB shows the transformation of HBeAg/Anti-HBe, HBV-DNA becoming negative, liver function returning to normal state, the disease is relieved. However, parts of patients with the transformation of HBeAg/Anti-HBe still remain positive in HBV-DNA and the pathological change in the liver continues. Because HBV-DNA occurs promoter mutation in the anterior C section (1896 necleoside G-A variation) or in the C section (1762 nucleoside T variation, 1764 G-A variation), HBeAg cannot come into being. Therefore, the HBeAg in the patient s blood cannot be detected, while the virus can keep on duplicating and fixing itself. Through sequential assay of nucleic acid, it proves that promoter mutation appears in 30%-60% of HBeAg negative Chronic Hepatitis B (CHB) in the anterior C section or in the C section. In some provinces and cities of the People of China, the percentage of promoter mutation appears in HBeAg negative Chronic Hepatitis B (CHB) in the anterior C section or in the C section is from 17.6% to 78.9%. Eight out of the 25 cases of our observation go through the sequential assay of nucleic acid carried out by the Department of Microbiology of the University of Hong Kong. It all proves to have HBV-DNA mutation. The chronic mutational Hepatitis B is infectious and apt to cause cirrhosis and liver cancer since the present medicines of antivirus and immuno-modulator do not produce the expected therapeutic effects.

Vitalliver suppository is made up from a formula of Chinese herbs, including Ginseng, Deer Horn, Cordyceps, Radix Astragali, Frudctus Cnidii, Semen Cuscutae, etc. The formula is mainly for strengthening the body resistant and primarily for reinforcing Kidney Qi, which produces good therapeutic effects in treating chronic mutational Hepatitis B. The mechanism is probably that through the regulating of immune system, the duplication of virus is inhibited and meanwhile the liver is protected, so it can produce a lasting therapeutic effect. No adverse reaction and severe accident happens during clinical observation, so it is safe for using. Vitalliver is bringing hopes to the treatment of chronic mutational Hepatitis B.

* The second stage of clinical trial would be carrying out by the Microbiology Department of the University of Hong Kong and Chengdu University of Traditional Chinese Medicine.

For more information, please visit: http://www.vigconic.com

Or, contact:

William Yip cs@vigconic.com
p>
5/F, Cheung Wah Building, Sheung Heung Rd,

Kowloon, Hong Kong

Tel: 852-27656200

Fax: 852-27645314
p>

Chengdu University of TCM, Hepatitis Laboratory in the attached hospital of Chengdu University of TCM, Sichuan, China

webmaster@vigconic.com

Hepatitis C - hbv_research

hbv_research
does not increase the efficacy of interferon in the treatment of mutant type chronic viral heaptitis B 23-Oct-2002 Hepatitis C and Hepatitis B Virus Infection in Different Hemodialysis Units in Belo

World J Gastroenterol
the efficacy of interferon in the treatment of mutant type chronic viral heaptitis B. World J Gastroenterol 2002; 8: 868-871 12 Terrault NA. Combined interferon and

USDA Funded Projects
diseases such as postweaning multisystemic wasting syndrome and Michigan rabbit viral heaptitis. E) Determine the effects of sample handling on laboratory tests for bovine tuberculosis. The

Hepatitis C - MedlinePlus: Hepatitis C

MedlinePlus: Hepatitis C
features links to news and articles about HCV infection, its symptoms and diagnosis, treatment options, prevention, alternative therapies, and support organizations.

NEJM -- Peginterferon Alfa-2a in Patients with Chronic Hepatitis C
Original Article from The New England Journal of Medicine -- Peginterferon Alfa-2a in Patients with Chronic Hepatitis C ... Interferon Alfa-2b, Plus Ribavirin, for Chronic Hepatitis C in HIV-Infected Patients: A ... Epidemiology, Diagnosis, and Treatment of Chronic Hepatitis C. Journal of Pharmacy Practice ...

Clinical Trial: Evaluating Silymarin for Chronic Hepatitis C
Evaluating Silymarin for Chronic Hepatitis C. This study is no longer recruiting patients. Information provided by: National Center for Complementary and Alternative Medicine (NCCAM) ClinicalTrials.gov Identifier: NCT00030030. Purpose

Hepatitis C - Hepatitis C - Page 1

Hepatitis C - Page 1
and the development of antibody screening tests, the number of newly acquired acute hepatitis C infection has decreased. In the 1980's, 180,000 cases were identified. At present, this rate has

Hepatitis C - Hep C Woman Bit Man On Ear

Hep C Woman Bit Man On Ear
Daily Record - UKLocalNews 23 November 2005 HEP C WOMAN BIT MAN ON EAR A DRUNK woman who knew she had hepatitis C bit a stranger's ear after he refused to dance with her.Fiona Manson's victim went through six

VX-950 Hep C Protease Inhibitor
National AIDS Treatment Advocacy Project - HW Reesnik reported these data today at AASLD oral session. VX950 Ki=7nM. Dose escalation study. Primary objective: assessment of safety. Secondary objective: assessment of PK and viral kinetics. PART A: 24 healthy subjects.

ViroPharma Hep-C drug promising
Business First of Louisville - ViroPharma Hep-C drug promising said Thursday preliminary results from a phase-I study of its experimental hepatitis C treatment, HCV-796, found the compound demonstrated antiviral effects.

Hepatitis C - MIGENIX Inc. (MGI.TO) Initiates Enrollment In Phase IIb Hepatitis C Clinical Study Of Celgosivir In Combinatio

MIGENIX Inc. (MGI.TO) Initiates Enrollment In Phase IIb Hepatitis C Clinical Study Of Celgosivir In Combinatio
BioSpace - 1 inhibitor, in development for the treatment of chronic hepatitis C virus (HCV) infections the success of treatment for patients suffering from chronic hepatitis C infections

XTL Biopharmaceuticals Ltd. (XTL.L) Announces Data Demonstrating The Antiviral Activity Of One Of The Two Anti
BioSpace - presently in Phase Ia clinical trial in patients with chronic hepatitis C. Results from this trial are expected in the

Hepatitis C - Man displaced by fire waits for transplant

Man displaced by fire waits for transplant
OA Online - Levesque, a Vietnam-era Army veteran, has lost his liver to a case of hepatitis C that went undiagnosed for years

Hepatitis C Caring Ambassadors Program Joins High School Students' Rally on Capitol Hill Calling for Passage o
Market Wire - OREGON CITY, OR -- (MARKET WIRE) -- 12/01/2005 -- At Robinson Secondary School in Fairfax, Virginia, the students in the marketing association (DECA) are working diligently to change of the outcome of the hepatitis C epidemic. change of the outcome of the hepatitis C epidemic. In an ongoing effort supported by the Hepatitis C Caring Ambassadors Program (HCCAP), the

Fighting Hepatitis C
US News - million people worldwide have been infected with the Hepatitis C virus that can cause liver failure, cancer, and makeup of people who had hepatitis C to try to find out

TopAbstracts in Hepatitis C 11/29/2005
Doctors Guide - Over 2000 peer-reviewed journals are covered by TopAbstracts. // TopAbstracts in Hepatitis C 11/29/2005 Unregistered User Hepatitis C SEARCH Doctor's Guide The Web

Cambridge biotech develops hepatitis C pill
Boston Herald - It exceeded our expectations. We think this is the most exciting drug possibility out there for all drugs, said Joshua Boger, president and chief executive of Vertex Pharmaceuticals Inc. scientists argue could cure more people with hepatitis C a virus that attacks the liver without the number of Americans infected with hepatitis C has been underestimated by about

Patients with Hepatitis C using more healthcare resources
EurekAlert! - Many patients contracted the disease in the 1970s before testing and safe needle-sharing practices were widespread. As this population ages, experts have predicted an increasing impact on the healthcare system. Patients with Hepatitis C using more healthcare resources Aging patient population burdens healthcare system Use care resources by patients with Hepatitis C has been rising 25 to

Hepatitis C - Hepatitis C: Early Detection Means Better Health(NC)-Experts estimate that 240,000

Hepatitis C: Early Detection Means Better Health

(NC)-Experts estimate that 240,000 people in Canada are currently infected with hepatitis C, of whom only 30% know they have the virus. The only way to find out for sure if you have hepatitis C is through a blood test. Your doctor can order one for you. By taking this action you'll be doing yourself a favour because hepatitis C can be treated only if it has been detected. Untreated hepatitis C can lead to severe conditions that require long-term, intensive care.

For more information visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.

Hepatitis C - MIGENIX Initiates Enrollment in Phase IIb Hepatitis C Clinical Study of Celgosivir

MIGENIX Initiates Enrollment in Phase IIb Hepatitis C Clinical Study of Celgosivir
BC Technology - glucosidase 1 inhibitor, in development for the treatment of chronic hepatitis C virus infections the success of treatment for patients suffering from chronic hepatitis C infections

Biolex Therapeutics begins trial of hepatitis C drug
Pharmaceutical Business Review - Biolex Therapeutics has revealed that the first cohort of subjects in the company's phase I study of investigational hepatitis C candidate, Locteron, have been dosed. initially for the treatment of patients with chronic hepatitis C. Locteron combines BLX-883, a recombinant under development for the treatment of patients with chronic hepatitis C.

Hepatitis C - Ways You Can Get Infected With Hepatitis C(NC)-Hepatitis C is

Ways You Can Get Infected With Hepatitis C

(NC)-Hepatitis C is spread through contact with infected blood. Here are just some of the ways in which you can be infected with this virus:

Sharing needles, straws, pipes, spoons and other drug-related equipment.

(At least two-thirds of all new hepatitis C infections are drug-use related. Cleaning equipment with bleach does not always effectively kill the virus) p>

Getting a tattoo, body piercing or acupuncture from an operator who does not use sterile equipment or techniques

Being born to a mother with hepatitis C

Getting pierced by a needle or sharp equipment that has infected blood on it ( in a hospital, workplace situation, etc.) p>

People who had blood transfusions before the testing of blood donations became mandatory in 1990 may also be at risk. And, while the risk is low, it is also possible to become infected by sharing personal household articles such as a razor or toothbrush with an infected person. The risk of transmission of hepatitis C during sex is also low, unless both parties have open bleeding sores.

It is estimated that 240, 000 people in Canada are currently infected with hepatitis C, of whom only 30% know they have the virus.

If you think you may be at risk, either now or from past risky activities see a doctor. The virus can be detected with a simple blood test, and there are steps and medications you can take to successfully minimize the effects of the disease if your diagnosis is positive. For more information, visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.

Hepatitis C - ADA.org: Dental Topics: Hepatitis C Virus (HCV)

ADA.org: Dental Topics: Hepatitis C Virus (HCV)
This page provides current information on the Hepatitis C Virus (HCV) as it relates to dental professionals. ... Americans are infected with hepatitis C virus (HCV) - four times the number infected with human immunodeficiency virus (HIV). Chronic HCV increases the risk of developing serious ...

ViroPharma Announces Data From HCV-086 Proof of Concept Study : ArriveNet Press Releases : Health
ViroPharma Announces Data From HCV-086 Proof of Concept Study EXTON, Pa. , March 10, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced re ... anti-viral effect of HCV-086 on HCV RNA concentrations in subjects with chronic HCV infection. In each of ...

ViroPharma Announces Advancement of HCV-796 Into Phase 1B Clinical Testing In Hepatitis C Patients
Source: ViroPharma Incorporated. ViroPharma Announces Advancement of HCV-796 Into Phase 1B Clinical Testing In Hepatitis C Patients. EXTON, Pa., ... clinical study in hepatitis C positive patients with HCV-796, a novel antiviral compound that the company is ... division of Wyeth (NYSE:WYE). HCV-796 is a potent orally dosed ...

Hepatitis C - The Hep C Connection (PDF)

The Hep C Connection (PDF)
... The Hep C Connection. Annual Report 2003 ... "The Denver Foundation is a Hep C. Connection funder ...

Delaware County Hep C Connect
Hepatitis Patient Sees Need, Forms Popular Support Group ... Donna Cowan founded the group "Delco Hep C Connect" in Aston, Pennsylvania last fall ... Thank you all who supported Delco Hep C Connect and the 2nd annual liver awareness ride ...

Hep C Aware - ARE YOU?
"Anyone who thinks they are too small to make a difference has never spent the night in a bedroom with a mosquito!" ( anonymous) Watch this year's. Hep C Aware: ... Determined to get the word out about Hep C, she put together shows, toured all over the country ... this mission, Kelly started the Hep C Postcard campaign and began building ...

Hepatitis C - Human Genome Sciences, Inc. (HGSI) Reports Interim Results Of Phase 2 Clinical Trial Of Albuferon(TM) in Combi

Human Genome Sciences, Inc. (HGSI) Reports Interim Results Of Phase 2 Clinical Trial Of Albuferon(TM) in Combi
BioSpace - combination with ribavirin (RBV) in patients with chronic hepatitis C who failed to respond to previous to Prior Interferon Therapy for Chronic Hepatitis C.'(1) The trial is

Schering-Plough Corporation (SGP)'s Oral HCV Protease Inhibitor Demonstrates Potent Antiviral Activity As Mono
BioSpace - representing an area of great unmet medical need. Chronic hepatitis C affects more than 10 million people in major world

Schering-Plough's Oral HCV Protease Inhibitor Demonstrates Potent Antiviral Activity as Monotherapy and in Com
Canada NewsWire - Results Reported at American Association for the Study of Liver Diseases (AASLD) Meeting Large Phase II Combination Study Under Way SAN FRANCISCO, Nov. representing an area of great unmetmedical need. Chronic hepatitis C affects more than 10 million people inmajor world

Hepatitis C - How to Choose a Doctor

How to Choose a Doctor
Title: How to Choose a Doctor
Category: Doctor's Views
Created: 6/17/2005
Last Editorial Review: 8/9/2005
Feedster
No Need to Click Here - I'm just claiming my feed at Feedster feedster:888c411b3cd68db1b26fa00bf9faaf81...
Liver Blood Tests
Title: Liver Blood Tests
Category: Procedures and Tests
Created: 6/2/1998
Last Editorial Review: 8/27/2005

Hepatitis C - A Summary of Chronic Hepatitis C InfectionHepatitis C is a

A Summary of Chronic Hepatitis C Infection

Hepatitis C is a stealthy virus that mutates while hiding in liver cells and other organ cells like the spleen and gall bladder. The fact that the viral cells "hide" makes it very difficult for the body's immune system to eradicate it. Hepatitis C is a slowly progressing disease sometimes taking many years until symptoms are noticeable. It is at this point that the virus has reached advanced chronic stage and becomes difficult to eradicate. Hepatitis C results in 8,000 to 10,000 deaths annually. Hepatitis C is also the leading cause of liver transplants in the U.S.

Hepatitis C infection is caused by blood contact with someone who has the virus infection himself. The transmission of the virus can occur by illicit drug use with needles, sharing toothbrushes or razors with an infected person, by sexual means, by unsanitary tattooing or by exposure to blood at your workplace (like a hospital or blood bank). Some HCV infection may have been caused by receiving blood from a transfusion prior to 1992.

Hepatitis C is diagnosed via a blood test. Usually, the first thing that is noticed is that the liver enzyme levels for ALT and AST are elevated well above normal levels. Further investigation via HCV-RNA testing identifies whether the Hepatitis C virus is in your blood or not. Other tests for HCV include qualitative viral load tests, which measure the RNA particles in your blood. If you are being treated for HCV, your doctor is probably using either a HCV-RNA or viral load test to determine the effectiveness of the treatment.

The symptoms of Hepatitis C infection often do not occur in a person until 20 years after he/she had been infected. Since the HCV infects the liver and the liver is the organ in the body that makes all the energy for our daily activities possible, liver function deterioration often results in fatigue. Fatigue is the primary complaint or symptom of HCV infection. Other more severe symptoms are jaundice (yellowing of the skin/eyes), bile retention (which can cause jaundice), portal vein hypertension, skin rashes and itching, and autoimmune problems resulting from your body's immune system attacking normal cells.

Long term HCV infection may result in fibrosis or even cirrhosis of the liver. Fibrosis results from unchecked liver inflammation. As the HCV infection progresses, the damage to the liver results in scarring or hardening of the liver cells (fibrosis). Long term fibrosis may lead to cirrhosis which is when the scarring from fibrosis overtakes the normal liver cell structure causing deformity and loss of function in the liver. About 15%-20% of HCV patients end up with cirrhosis. A liver biopsy is currently the most accurate means of determining the amount of inflammation and fibrosis the liver has sustained.

Hepatitis C progression in the body can take several years or even decades to come to chronic stage or to a stage where severe liver damage is evident. This period of time allows a person to determine how to properly treat the disease and to decide on a course of disease management. Currently, the main treatment for HCV infection to eradicate the virus is combo alpha-interferon and Ribavirin. Sometimes a doctor may prescribe interferon alone. Interferon comes in standard form or in pegylated form. Standard form interferon is administered 3 times per week, while the pegylated form is administered only once per week. Your body makes its own interferon, which is a protein that fights viral infection and viral replication.

Hepatitis C may often be managed by taking herbal and vitamin supplements that help your body fight infection and limit inflammation. These supplements help your liver with the inflammation and give it the nutrients it needs to regenerate healthy new cells. Your doctor can recommend alternative or adjunct solutions you may want to try.

Proper treatment of the disease, a healthy and active lifestyle, a good diet, abstinence from alcohol and stress management are important factors in controlling Hepatitis C progression.

About the Author

Greg Lietz is a freelance writer and internet businessman. His main website is http://www.theonlinebizplace.com where he provides content about internet based business opportunities and different niche interests. This article may be freely printed when the bio information is included.

Hepatitis C - Vaccination Tames Hepatitis A Infection

Vaccination Tames Hepatitis A Infection
Title: Vaccination Tames Hepatitis A Infection
Category: Health News
Created: 7/13/2005 1:58:00 AM
Last Editorial Review: 7/13/2005 1:58:14 AM
Vertex Progresses with VX-950
Okay, okay, again I say, Vertex is the race horse to watch right now. They are progressing quicky on their preliminary good results. While it's not yet time to line up for their treatment. I believe theirs will be first...
Ultrasound
Title: Ultrasound
Category: Procedures and Tests
Created: 12/31/1997
Last Editorial Review: 10/15/2005
Early treatment of hepatitis C effective in HIV-positive patients
Blink: Hepatitis C Bio, Pics, News and Views from BlinkBits
Subject: Early treatment of hepatitis C effective in HIV-positive patients
Added by mfeed on Nov 29, 2005 9:08 pm (GMT -4)

Aidsmap - ... Treatment of hepatitis C infection during the early phase of infection can achieve similar response rates ... Liver diseases including hepatitis C are an important cause of disease in ...... Read more...

Original Bit Published: 29 Nov 05 00:00:00 PST

Alcohol Impairment Chart
Title: Alcohol Impairment Chart
Category: Health Fact Tool
Created: 8/10/2005
Last Editorial Review: 8/29/2005

Hepatitis C - Hepatitis C Virus Lives In Your Liver(NC)-Your liver works 24

Hepatitis C Virus Lives In Your Liver

(NC)-Your liver works 24 hours a day, performing over 500 vital functions for your body. Most of the blood that returns to your heart passes through the liver. Your body can't function without it.

The hepatitis C virus lives in your liver. It inflames liver cells, which, over time, affects the way your liver functions. The effect of the hepatitis C virus varies from person to person. There is no way to predict how your body will react to it. There are, however, some things that are known:

You can live with hepatitis C for many years without experiencing any major symptoms, or you might simply feel tired. Symptoms can come and go over time. Their presence or absence does not tell you the degree to which liver damage may or may not be occurring. p>

Chronic, long-term inflammation of the liver can cause liver cell damage and result in fibrosis (liver scarring), or even cirrhosis. This damage can occur in as little as five years, or as long as 30 years.

About 20% of chronic hepatitis patients develop cirrhosis within 10 to 20 years.

Use of recreational drugs or alcohol can speed up inflammation and the development of fibrosis or cirrhosis.

There is an increased risk of liver cancer in people with cirrhosis.

The good news is that current drug treatments can be very effective for people with hepatitis C. Combined with proper nutrition, plenty of rest, and avoidance of recreational drugs and alcohol, these treatments help many who have the virus lead relatively healthy lives.

If you think you may be at risk of getting hepatitis C, see your doctor. The virus can be detected by a simple blood test. For more information on how to keep your liver happy and healthy, visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

p>

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services. p>

Hepatitis C - New Hampshire Public Radio Series Examines 'Building Wave' of Hepatitis C in State

New Hampshire Public Radio Series Examines 'Building Wave' of Hepatitis C in State
Gay.com - NHPR requested from the data on New Hampshire hospital discharges from 1996 to 2003. Series Examines 'Building Wave' of Hepatitis C in StateNovember 08, 2005 's 'NHPR ' last week aired a two-part series, titled 'Hepatitis C: The Uncounted Disease,' that examined

Proven Herbal Remedy Uses Chinese Medicine to Fight Hepatitis C Liver Disease Naturally and Restore Overall He
PR.com - Nu-Liver, a natural herbal formula for hepatitis c can normalize liver enzymes, lower viral loads, and halt the progression of hepatitis c disease. from the Orient that reverses hepatitis c liver disease safely, is now

Treatment of Genotype 1 Chronic Hepatitis C: Increased Sustained Virological Response with High-dose RBV and E
HIV and Hepatitis.com - RBV dose reductions also are associated with decreased SVR. clinical trials have shown that hepatitis C virus (HCV)-infected patients treated

Healthbeat:Hepatitis C
WHOI - Healthbeat:Hepatitis C November 24, 2005 Jen Christensen Hepatitis C Hepatitis C is a prevalent blood-borne infection caused by the hepatitis C virus (HCV). The virus causes an infection of the liver, which initiates swelling.

Rescuers Screened for Hepatitis C
KSLA - Rescuers Screened for Hepatitis C Latest News The Shreveport fire department is on the look out for a so called silent epidemic. It teamed up with the American Liver Foundation to offer free screening for Hepatitis C.

Hepatitis C - Is There A Vaccine For Hepatitis C?(NC)-No, not for hepatitis

Is There A Vaccine For Hepatitis C?

(NC)-No, not for hepatitis C. There are vaccines for hepatitis A and hepatitis B. To prevent further damage to your liver, your doctor may advise you to be vaccinated against hepatitis A and hepatitis B.

Could I give hepatitis C to someone else?

Yes, as far as we know, once you have hepatitis C, you can always transmit it to someone else if they come in contact with your blood. If you have hepatitis C, you can't donate blood. You should avoid sharing personal items like razors and toothbrushes, because the virus is spread through blood to blood contact.

Although the virus isn't spread easily by sexual contact or from a mother to her unborn baby, the risk of transmitting the virus is not absent. Therefore, talk to your doctor first if you want to have children. p>

For more information on hepatitis C visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.

Hepatitis C - How to Choose a Doctor

How to Choose a Doctor
Title: How to Choose a Doctor
Category: Doctor's Views
Created: 6/17/2005
Last Editorial Review: 8/9/2005
VX-950 Making Progress
Here's an exciting one, VX-950 we've been watching for a while. This protease inhibitor is making good progress (and it is orally administered, no less). While it is being studied as another Interferon treatment enhancer, it could be very helpful...
Fatty Liver
Title: Fatty Liver
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 8/29/2005
Patients with Hepatitis C using more healthcare resources
Blink: Hepatitis C Bio, Pics, News and Views from BlinkBits
Subject: Patients with Hepatitis C using more healthcare resources
Added by mfeed on Nov 29, 2005 9:08 pm (GMT -4)

EurekAlert! - Many patients contracted the disease in the 1970s before testing and safe needle-sharing practices were widespread. As this population ages, experts have predicted an increasing impact on the healthcare system. ... Patients with Hepatitis C using more healthcare resources Aging patient population burdens healthcare system Use ... care resources by patients with Hepatitis C has been rising 25 to ...... Read more...

Original Bit Published: 29 Nov 05 00:00:00 PST

Hepatitis C - PR Newswire: Data on Schering-Plough's Oral HCV Protease Inhibitor to be Presented for First Time at American

PR Newswire: Data on Schering-Plough's Oral HCV Protease Inhibitor to be Presented for First Time at American
Belga Direct Press Releases - News Wires KENILWORTH, New Jersey, November 7 /PRNewswire/ -- - Final Results of PEGINTRON(R) Combination Therapy Studies Also PresentedImportant new data on Schering-Plough's investigational oral development for treating hepatitis C virus (HCV) infection will be presentedfor the first for liver transplant in Europe.HCV Protease Inhibitor (SCH 503034)Oral PresentationsAnti

Schering-Plough's Oral HCV Protease Inhibitor Demonstrates Potent Antiviral Activity as Monotherapy and in Com
Canada NewsWire - Results Reported at American Association for the Study of Liver Diseases (AASLD) Meeting Large Phase II Combination Study Under Way SAN FRANCISCO, Nov. chronically infected with hepatitis Cvirus (HCV) genotype 1 who were nonresponders to therapy, includingpeginterferon combination therapy. HCV genotype 1 is the most common form

Safety and Efficacy of Pegasys Plus Ribavirin in HCV Patients Intolerant or Nonresponsive to Treatment with Pe
HIV and Hepatitis.com - RBV dose reductions also are associated with decreased SVR. Era of Protease Inhibitors for the Treatment of HCV: An Overview of SCH 503034 SCH 503034 is a new, orally administered HCV protease inhibitor that has shown potent

Virological And Histological Features Of Hcv In Patients With Normal Alt: Results Of A Ten Year Propsective Fo
National AIDS Treatment Advocacy Project - histology worsened in 20.8% of anti HCV+ve pts with persistently normal ALT --Neither serum HCV-RNA nor ALT level can reliably

InterMune Sharpens Focus on Key Development Programs and Significantly Strengthens Financial Position
PR NewsWire via Forbes.com - in Cash - - Retains Full Ownership of HCV Protease Inhibitor Program - - Reduces Annual Operating IPF), pirfenidone for IPF, and the hepatitis C virus (HCV) protease inhibitor

Hepatitis C - ILAR Journal Online, Volume 42(2) 2001: Animal Models of Hepatitis

ILAR Journal Online, Volume 42(2) 2001: Animal Models of Hepatitis
Barker, LF, Maynard JE, Purcell RH, Hoofnagle JH, Berquist KR, London WT. 1975. Viral heaptitis, type B in experimental animals. Am J Med Sci 270:189-195. Bassett SE, Thomas D, Brasky, KM, Lanford RE

USDA Funded Projects
diseases such as postweaning multisystemic wasting syndrome and Michigan rabbit viral heaptitis. E) Determine the effects of sample handling on laboratory tests for bovine tuberculosis. The

World J Gastroenterol
the efficacy of interferon in the treatment of mutant type chronic viral heaptitis B. World J Gastroenterol 2002; 8: 868-871 12 Terrault NA. Combined interferon and

Hepatitis C - Immunization: National Immunization Awareness Month

Immunization: National Immunization Awareness Month
Title: Immunization: National Immunization Awareness Month
Category: Health Facts
Created: 8/1/2005
Last Editorial Review: 8/1/2005
Japanese Researchers Make Progress
This article is from one of the largest Japanese newspapers. As it shows, researchers in Japan are also working hard to develop a better treatment for HCV. Scientists the world over are doing their best to find a less toxic...
Primary Biliary Cirrhosis
Title: Primary Biliary Cirrhosis
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 9/17/2005
Major Depressive Disorder in Hepatitis C: An Open-Label Trial of
Blink: Hepatitis C Bio, Pics, News and Views from BlinkBits
Subject: Major Depressive Disorder in Hepatitis C: An Open-Label Trial of
Added by glog on Nov 28, 2005 5:28 am (GMT -4)

... MA Background: Depression is a common condition associated with hepatitis C and may be induced by interferon alfa, the primary treatment for hepatitis C. Depression is also a major barrier to the initiation of such treatment. ...... Read more...

Hepatitis C - Doctor: Getting the Most from Your Doctor s Appointment

Doctor: Getting the Most from Your Doctor s Appointment
Title: Doctor: Getting the Most from Your Doctor s Appointment
Category: Doctor's Views
Created: 5/13/2005
Last Editorial Review: 5/13/2005
Vertex Progresses with VX-950
Okay, okay, again I say, Vertex is the race horse to watch right now. They are progressing quicky on their preliminary good results. While it's not yet time to line up for their treatment. I believe theirs will be first...
How to Choose a Doctor
Title: How to Choose a Doctor
Category: Doctor's Views
Created: 6/17/2005
Last Editorial Review: 8/9/2005

Hepatitis C - Treating Chronic Mutational Hepatitis B with Chinese Medicine Vitalliver (Vigconic

Treating Chronic Mutational Hepatitis B with Chinese Medicine Vitalliver (Vigconic Suppositories)

Treating chronic mutational hepatitis B with Chinese medicine Vitalliver (Vigconic suppositories)

ZHANG GUAN HUA, LIANG CHAO, ZHENG WAN PIN

Chengdu University of TCM, Hepatitis Laboratory in the attached hospital of Chengdu University of TCM, Sichuan, China

Research Method:

Quantitative determination by contrasting HBV-DNA of cases before and after the treatment.

Number of cases: 25 (n)

Case Selection: Between the age of 16 and 65, in accordance with the diagnosis standards pf chronic Hepatitis B, with negative e antigen and positive e antibody, HBV-DNA > 1 104 cp/mL.

Detection Method: All the blood samples are detected by Sichuan Clinical Detection Center; PCR-ELISA quantitative determination is used within detection range of 1 104 - 1 107-8, HBV-DNA, unit of measurement is cp/mL.

Direction Plan: one suppository provided by Vigconic (International) Ltd. Bid. The course of treatment is six months, the tracing observation after withdrawal lasts six months.

Observation index:

1. HBV-DNA response after the treatment.
   

2. Lasting HBV-DNA response (six months after withdrawal).
   p>

Criterion of Therapeutic Effect:

1. If HBV-DNA volume 1 104 cp/mL: 4/25 (16%)
   

2. Lasting response:
   

HBV-DNA volume 1 104 cp/mL: 2/25 (8%)

Among the results of lasting response, 16 blood serum samples are detected through fluorimetric quantitative determination PCR by the instruments of PE.USD, H-7700 in the second attached hospital of Guangzhou Medical College. The result is in accordance with that in Sichuan Clinical Testing Center. (8 cases among it 1 102 cp/mL). The testing range of this testing method is 1 102 - 1 107-8 cp/mL.

Conclusion

The reason for the repeatedly abnormal liver function of Chronic Hepatitis B (CHB) patients lies in the repeatedly duplication of HBV after infection, which leads to fibrosis of liver, then cirrhosis and liver cancer. It is commonly accepted that if CHB shows the transformation of HBeAg/Anti-HBe, HBV-DNA becoming negative, liver function returning to normal state, the disease is relieved. However, parts of patients with the transformation of HBeAg/Anti-HBe still remain positive in HBV-DNA and the pathological change in the liver continues. Because HBV-DNA occurs promoter mutation in the anterior C section (1896 necleoside G-A variation) or in the C section (1762 nucleoside T variation, 1764 G-A variation), HBeAg cannot come into being. Therefore, the HBeAg in the patient s blood cannot be detected, while the virus can keep on duplicating and fixing itself. Through sequential assay of nucleic acid, it proves that promoter mutation appears in 30%-60% of HBeAg negative Chronic Hepatitis B (CHB) in the anterior C section or in the C section. In some provinces and cities of the People of China, the percentage of promoter mutation appears in HBeAg negative Chronic Hepatitis B (CHB) in the anterior C section or in the C section is from 17.6% to 78.9%. Eight out of the 25 cases of our observation go through the sequential assay of nucleic acid carried out by the Department of Microbiology of the University of Hong Kong. It all proves to have HBV-DNA mutation. The chronic mutational Hepatitis B is infectious and apt to cause cirrhosis and liver cancer since the present medicines of antivirus and immuno-modulator do not produce the expected therapeutic effects.

Vitalliver suppository is made up from a formula of Chinese herbs, including Ginseng, Deer Horn, Cordyceps, Radix Astragali, Frudctus Cnidii, Semen Cuscutae, etc. The formula is mainly for strengthening the body resistant and primarily for reinforcing Kidney Qi, which produces good therapeutic effects in treating chronic mutational Hepatitis B. The mechanism is probably that through the regulating of immune system, the duplication of virus is inhibited and meanwhile the liver is protected, so it can produce a lasting therapeutic effect. No adverse reaction and severe accident happens during clinical observation, so it is safe for using. Vitalliver is bringing hopes to the treatment of chronic mutational Hepatitis B.

* The second stage of clinical trial would be carrying out by the Microbiology Department of the University of Hong Kong and Chengdu University of Traditional Chinese Medicine.

For more information, please visit: http://www.vigconic.com

Or, contact:

William Yip cs@vigconic.com
p>
5/F, Cheung Wah Building, Sheung Heung Rd,

Kowloon, Hong Kong

Tel: 852-27656200

Fax: 852-27645314
p>

Chengdu University of TCM, Hepatitis Laboratory in the attached hospital of Chengdu University of TCM, Sichuan, China

webmaster@vigconic.com

Hepatitis C - Hepatitis, Inflammation [Liver]

Hepatitis, Inflammation [Liver]
... Neo-Minophagen C (SNMC) on hepatic histography in non-A, non-B chronic active hepatitis. In Viral Hepatitis C, D, E, ed ...

Hepatitis C - What is Hepatitis C?(NC)-Hepatitis C is an infectious virus that

What is Hepatitis C?

(NC)-Hepatitis C is an infectious virus that is carried in the blood and harms the liver. About 240,000 Canadians are infected, many of whom are unaware that they even have it. The number of people with hepatitis C is increasing in Canada and around the world, primarily among those who share needles and other drug equipment. An estimated 5,000 Canadians - mostly young people - get this virus each year. p>

Although the hepatitis C virus has been around for a long time, it was only identified in 1989. It causes inflammation of the liver, which often progresses to cirrhosis (scarring that makes it difficult for the liver to function normally). Of the estimated 5,000 people that are newly infected each year, up to 70 percent experience no symptoms. For some, symptoms may not show up for 20 or 30 years. In the meantime, they may, unknowingly, be infecting others. That is why it is important to know if you are at risk and how to take preventative action.

If you think you have hepatitis C, or that you may be at risk, visit your doctor and ask for the simple blood test for this disease. For more information, contact a health care professional, and visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.

Hepatitis C - International anti-HCV External Quality Assessment Scheme (EQAS) (PDF)

International anti-HCV External Quality Assessment Scheme (EQAS) (PDF)
Report on Testing of the Anti-HCV External Quality Assessment Scheme Panel 8 - 2003. International anti-HCV External Quality Assessment Scheme. (EQAS) Organised by the National Serology Reference Laboratory, Australia

HCV
Current therapy and prophylaxis for the hepatitis c virus. ... its genes, it was called hepatitis C virus (HCV). Cloning of the viral genes made it possible to ... tests for the diagnosis of HCV infection, revealing for the first time ...

hcv (MICROSOFT WORD)
Diagnostic Automation Inc. EIA KIT FOR THE DETECTION OF. HCV Ab. Cat. No.: 1707-4. For in vitro Diagnostic Use. Product Insert ... HCV is the etiological agent responsible for the disease known as Non-A, Non-B Hepatitis, or Hepatitis ... microplate well is coated with HCV specific antigen, and sealed in an ...

Hepatitis C - Peregrine Pharmaceuticals, Inc. (PPHM) to Present At Rodman & Renshaw Annual Healthcare Conference

Peregrine Pharmaceuticals, Inc. (PPHM) to Present At Rodman & Renshaw Annual Healthcare Conference
BioSpace - program, including its ongoing clinical trial for hepatitis C infection and preclinical programs in influenza and other

Ciphergen and University of Texas Medical Branch at Galveston Sign Collaboration Agreement in Liver Disease
PR Newswire - Professor of Internal Medicine atUTMB, have been studying how Hepatitis C infection can damage or destroy theliver

OctoPlus Initiates Clinical Trials With Locteron(TM), a Controlled Release Formulation of Alfa Interferon
PR Newswire via Yahoo! - Alfa interferon is a protein used to treat infectious diseases, such as hepatitis B and C, and certain cancers. treatment of its primary indication, chronic hepatitis C infection.Locteron combines OctoPlus' proprietary PolyActive(TM

Peregrine Pharmaceuticals to Present at Rodman & Renshaw Annual Healthcare Conference
PR Newswire via Yahoo! - program, including its ongoing clinical trial for hepatitis C infection and preclinical programs in influenza and other

Early treatment of hepatitis C effective in HIV-positive patients
Aidsmap - Liver diseases including hepatitis C are an important cause of disease in HIV-positive patients. Treatment of hepatitis C infection during the early phase of infection can achieve similar response Although the treatment of chronic hepatitis C infection in HIV-positive patients

Hepatitis C - Genotypes in patients with viral hepatitis C

Genotypes in patients with viral hepatitis C
Genotypes in patients with viral hepatitis C Genotypes in patients with viral hepatitis C Hepatitis C virus (HCV) is a small single stranded RNA virus, that belongs to the Flaviviridae family. HCV can be classified into six major genotypes and ...

Viral hepatitis C.
... The state of the art may have changed since the publication date. Viral hepatitis C. ...

Hepatitis C - Idenix Pharmaceuticals: HCV

Idenix Pharmaceuticals: HCV
... disease caused by the hepatitis C virus (HCV). HCV infection becomes chronic in 75 to 85 percent ... in the United States. Chronic HCV infection inflames the liver, causing progressive ...

International anti-HCV External Quality Assessment Scheme (EQAS) (PDF)
Report on Testing of the Anti-HCV External Quality Assessment Scheme Panel 8 - 2003. International anti-HCV External Quality Assessment Scheme. (EQAS) Organised by the National Serology Reference Laboratory, Australia

Preventing HCV in Scotland: Options for action (PDF)
... Preventing HCV in Scotland: Options for action ... 22333_mm_hcv_blet 18/3/02 4:00 Page 1 ...

HCV PCR definition - Medical Dictionary definitions of popular medical terms
Online Medical Dictionary and glossary with medical definitions ... HCV PCR: HCV PCR (polymerase chain reaction) is a test for the hepatitis C virus (HCV). ...

Hepatitis C - eMedicine - Hepatitis C : Article by Sandeep Mukherjee, MD

eMedicine - Hepatitis C : Article by Sandeep Mukherjee, MD
Forman LM, Lewis JD, Berlin JA, et al: The association between hepatitis C infection and survival after orthotopic liver transplantation.

Hepatitis C: Tattoo | CDC Viral Hepatitis
CDC's Position on Tattooing and HCV Infection. Although some studies have found an association between tattooing and HCV infection in very selected

Hepatitis C: An Epidemic for Anyone
Hepatitis C infection is typically mild in its early stages, and it is rarely recognized until it has caused significant damage to the liver.

Hepatitis Information Network: HepNet - Hepatitis C
How significant is hepatitis C infection in Canada? by M. Sherman, Hepatologist. High risk Individuals - Who are they? Slide Show: Seroprevalence and Risk

Hepatitis C - Hepatitis C (Advanced)

Hepatitis C (Advanced)
... for HCV RNA is a reliable way of demonstrating that hepatitis C infection is present and is the most specific test for ...

Chronic Hepatitis C
A clinician's guide to the medical management of Hepatitis C. ... is a reliable way of demonstrating that hepatitis C infection is present and is the most ... The natural history of chronic hepatitis C infection. European Journal of Gastroenterology ...

Chronic Hepatitis Infection (PDF)
... From 1998 through 2003, there were 40,427 cases of chronic Hepatitis C infection reported in ... nation , there are an estimated 92,000 individuals with Hepatitis C infection in Arizona ...

Hepatitis C - Is There A Vaccine For Hepatitis C?(NC)-No, not for hepatitis

Is There A Vaccine For Hepatitis C?

(NC)-No, not for hepatitis C. There are vaccines for hepatitis A and hepatitis B. To prevent further damage to your liver, your doctor may advise you to be vaccinated against hepatitis A and hepatitis B.

Could I give hepatitis C to someone else?

Yes, as far as we know, once you have hepatitis C, you can always transmit it to someone else if they come in contact with your blood. If you have hepatitis C, you can't donate blood. You should avoid sharing personal items like razors and toothbrushes, because the virus is spread through blood to blood contact.

Although the virus isn't spread easily by sexual contact or from a mother to her unborn baby, the risk of transmitting the virus is not absent. Therefore, talk to your doctor first if you want to have children. p>

For more information on hepatitis C visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.

Hepatitis C - Liver Histology and Alanine Aminotransferase Levels in Children and Adults with Chronic Hepatitis C Infection

Liver Histology and Alanine Aminotransferase Levels in Children and Adults with Chronic Hepatitis C Infection
HIV and Hepatitis.com - has been shown to correlate with duration of infection regardless of age.

Ciphergen Biosystems, Inc. (CIPH) And University of Texas Medical Branch At Galveston Sign Collaboration Agree
BioSpace - Professor of Internal Medicine at UTMB, have been studying how Hepatitis C infection can damage or destroy the liver

Call for free condoms to combat spread of HIV in prisons
Guardian Unlimited - Prison healthcare, the report authors say, is 'substandard' and many prisoners have no access to condoms, disinfecting tablets, clean needles or healthcare information. tests to establish more accurate levels of HIV and hepatitis C infection.In order to avoid the spread of sexually

Peregrine Pharmaceuticals Names Leading Viral Experts to Its Scientific Resource Board
PR Newswire - Phase I clinical trial forthe treatment of chronic hepatitis C infection (HCV) and is being studiedpreclinically for use

Hepatitis C - Hepatitis C

Hepatitis C
Hepatitis C Scope of Problem and Trends Hepatitis C is caused by the hepatitis C virus (HCV), a blood borne infectious agent. The incidence of new HCV infections rose steadily through the 1960s and

Hepatitis C - Web HIV/HCV pocket guide (PDF)

Web HIV/HCV pocket guide (PDF)
CLINICIAN'S GUIDE. TO HIV/HCV. CO-INFECTION. Belinda Brown ND, FNP. Constance Benson MD. Lucy Bradley-Springer PhD, RN, ACRN. Center of Excellence. Belinda Brown ND, FNP. Mountain Plains AIDS Education and Training Center. Constance Benson MD ... overall are co-infected with HCV; HCV co-infection ... who acquired HIV through IV drug use, the rate of. HIV/HCV co-infection may exceed 75-90%. ...

All About Hepatitis C - Hepatitis C statistics on those who are infected with hep C
Hepatitis C statistics on populations who are at increased risk for hep C. ... The highest rates of HCV infection are among IV drug users--70% to 90% of IV drug users have HCV infection ...

U.S. Department of Housing and Urban Development (PDF)
... Some HCV program participants are considered by HUD to be hard-to-house ... For persons with disabilities, finding accessible housing in the. HCV program can be a major challenge ...

HIV/HCV Co-infection FAQs and Case Studies
FAQs/Cases. A list of frequently asked questions about HIV/HCV co-infection submitted by clinicians. If you have a question you would to present to the Center of Excellence, please contact us. ... Click on the link to explore issues in HIV/HCV co-infection management ...

Housing Choice Vouchers - HUD
The Office of Public and Indian Housing ensures safe, decent, and affordable housing, creates opportunities for residents' self-sufficiency and economic independence, and assures the fiscal integrity of all program participants

Hepatitis C - National Hepatitis C Advocacy Council, - Main Index

National Hepatitis C Advocacy Council, - Main Index
The National Hepatitis C Advocacy Council has been formed in an effort to bring together the collective strengths of hepatitis C patient advocacy organizations.

Medscape Resource Center - Hepatitis C
November 25, 2005. Hepatitis C. Resource Center. Collections of Medscape's key clinical content, selected by our editors - Last updated 11/16/2005. Sections. Overview Content. The prevalence of hepatitis C virus infection is increasing worldwide.

Hep Helper
daily regimen of vitamins and organic herbs to manage Hepatitis C.

Hepatitis C
Background. For a very long time, this hepatitis had no identity except as non-A, non-B hepatitis. It was a diagnosis of exclusion. In 1989, the hepatitis C virus was discovered.

Heroinegirl Hep C treatment
Treatment...it was the best of times...it was the worst of times. It is what it is.. One day at a time.. ... levels will sustain a negative result! The Hep C virus is still non-present which is good news ... least I can work with Hep C patients in the future, knowing ...

Hepatitis C - Hepatitis C: All-about-hepatitisC treatments, risk factors, and

Hepatitis C: All-about-hepatitisC treatments, risk factors, and
Hepatitis C resources on hep C causes, symptoms, testing, and treatments.

HCV Advocate.org
Resource Library | About HCSP | Contact Us | Site Map | Recursos en Espa ol | Home (C) 2005. Hepatitis C Support Project Hepatitis C Support Project

VA National Hepatitis C Program
The Veterans Affairs National Hepatitis C Web site provides information about viral hepatitis for health care providers inside and outside the VA system,

Hepatitis C Association, Hepatitis C awareness, donor support, and
The focus of the Hepatitis C Association is to educate the public, both medical professionals and private citizens, about hepatitis C virus.

Hepatitis C - World J Gastroenterol

World J Gastroenterol
does not increase the efficacy of interferon in the treatment of mutant type chronic viral heaptitis B. Yang SS, Hsu CT, Hu JT, Lai YC, Wu CH. World J Gastroenterol 8(5):868-871 Mutational

hbv_research
does not increase the efficacy of interferon in the treatment of mutant type chronic viral heaptitis B 23-Oct-2002 Hepatitis C and Hepatitis B Virus Infection in Different Hemodialysis Units in Belo

World J Gastroenterol
the efficacy of interferon in the treatment of mutant type chronic viral heaptitis B. World J Gastroenterol 2002; 8: 868-871 12 Terrault NA. Combined interferon and

Hepatitis C - AASLD Presentations Support the Initiation of a Broad Phase II Program with VX-950, an Investigational Oral HC

AASLD Presentations Support the Initiation of a Broad Phase II Program with VX-950, an Investigational Oral HC
Doctors Guide - Vertex Announces Filing of IND in Support of VX-950 Phase II Development in the U.S. dose-ranging Phase Ib study of VX-950 dosed in an oral suspension for 14 days in patients with chronic hepatitis C. Dr.

ViroPharma Announces That Treatment With HCV-796 Reduces Hepatitis C Virus Levels
Primezone Media Network - NYSE:WYE). In this trial, HCV-796 demonstrated antiviral effects in adult patients with chronic hepatitis C infection

Schering-Plough's Oral HCV Protease Inhibitor Demonstrates Potent Antiviral Activity as Monotherapy and in Com
Canada NewsWire - Results Reported at American Association for the Study of Liver Diseases (AASLD) Meeting Large Phase II Combination Study Under Way SAN FRANCISCO, Nov. representing an area of great unmetmedical need. Chronic hepatitis C affects more than 10 million people inmajor world

Hepatitis C - ILAR Journal Online, Volume 42(2) 2001: Animal Models of Hepatitis

ILAR Journal Online, Volume 42(2) 2001: Animal Models of Hepatitis
... LF, Maynard JE, Purcell RH, Hoofnagle JH, Berquist KR, London WT. 1975. Viral heaptitis, type B in experimental animals ...

USDA Funded Projects
... as postweaning multisystemic wasting syndrome and Michigan rabbit viral heaptitis. E) Determine the effects of sample ...

Untitled Document
... There are, however, non-viral heaptitis caused by drugs, alcoholic and toxi elements. ...

Hepatitis and Health news and miscellaneous communications hepatitis-news-1002-18
... does not increase the efficacy of interferon in the treatment of mutant type chronic viral heaptitis B ... mutant type chronic viral heaptitis B. Yang SS, Hsu CT, Hu ...

Hepatitis C - MIGENIX Inc. (MGI.TO) Initiates Enrollment In Phase IIb Hepatitis C Clinical Study Of Celgosivir In Combinatio

MIGENIX Inc. (MGI.TO) Initiates Enrollment In Phase IIb Hepatitis C Clinical Study Of Celgosivir In Combinatio
BioSpace - 1 inhibitor, in development for the treatment of chronic hepatitis C virus (HCV) infections the success of treatment for patients suffering from chronic hepatitis C infections

InterMune, Inc. (ITMN) Announces Clinical Data Presented At AASLD That Support Phase III DIRECT Trial For HCV
BioSpace - Consensus Interferon and Ribavirin in Patients with Chronic Hepatitis C who were Non-responders to Prior Therapy with

Cryoglobulinemia Is Associated With Steatosis And Fibrosis In Chronic Hcv
National AIDS Treatment Advocacy Project - No study has focused on the relationship between presence of cryoglobulin and liver steatosis which is associated with progression of liver disease. large population of patients with chronic hepatitis C, an independent association between cryoglobulin Paris, France Background and Aim: Chronic hepatitis C virus (HCV) infection is

Plymouth woman backs campaign to raise awareness of hepatitis C
Plymouth Evening Herald - is estimated that 200,000 people in England have chronic hepatitis C infection, the majority of whom are unaware of

Cambridge biotech develops hepatitis C pill
Boston Herald - Many people with chronic hepatitis C dont choose to get the current therapy because of horrible side effects that

Hepatitis C - WHO | Hepatitis C

WHO | Hepatitis C
No vaccine is currently available to prevent hepatitis C and treatment for chronic hepatitis C is too costly for most persons in developing countries to afford. Thus, from a global perspective, the

Brian's Chronic Hepatitis Home Page
enzymes and a positive antibody test for HCV (anti-HCV) means that an individual has chronic hepatitis C. The anti-HCV test will remain positive for several years after recovery from acute hepatitis C

T-Net: News
Vancouver, BC, September 27, 2005--(T-Net)--MIGENIX Inc. has completed a Phase IIa monotherapy clinical study of celgosivir, an orally administered, first-in-class, a-glucosidase I inhibitor, in

Hepatitis C - Management of Chronic Hepatitis C: Clinical Focus

Management of Chronic Hepatitis C: Clinical Focus
How well do the results of initial liver biopsy predict measures of disease progression and outcomes of treatment in patients with chronic hepatitis C,

Hepatitis C: Current Treatment
Patients with chronic hepatitis C should consult their doctors regarding possible The main goal of treatment of chronic hepatitis C is to eliminate

Hepatitis C - Review of the Evidence: Screening for Hepatitis C Virus Infection

Review of the Evidence: Screening for Hepatitis C Virus Infection
Cohard M, et al. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration. Hepatology 1996;24(4):778-89. 119. Kjaergard LL, Krogsgaard K, Gluud

Hepatitis C - The Body: Viral Hepatitis C

The Body: Viral Hepatitis C
Viral Hepatitis C, at The Body, the complete HIV/AIDS resource.

Viral Hepatitis C
In summary, viral hepatitis C has a long natural history with mostly benign course Viral hepatitis C infection induces the general changes of hepatitis,

Selected Major Viral Hepatitis Web Sites
The Department of Veterans Affairs leads the country in hepatitis C screening, treatment, research and prevention. This is a list of government, academic,

Hepatitis C - A Summary of Chronic Hepatitis C InfectionHepatitis C is a

A Summary of Chronic Hepatitis C Infection

Hepatitis C is a stealthy virus that mutates while hiding in liver cells and other organ cells like the spleen and gall bladder. The fact that the viral cells "hide" makes it very difficult for the body's immune system to eradicate it. Hepatitis C is a slowly progressing disease sometimes taking many years until symptoms are noticeable. It is at this point that the virus has reached advanced chronic stage and becomes difficult to eradicate. Hepatitis C results in 8,000 to 10,000 deaths annually. Hepatitis C is also the leading cause of liver transplants in the U.S.

Hepatitis C infection is caused by blood contact with someone who has the virus infection himself. The transmission of the virus can occur by illicit drug use with needles, sharing toothbrushes or razors with an infected person, by sexual means, by unsanitary tattooing or by exposure to blood at your workplace (like a hospital or blood bank). Some HCV infection may have been caused by receiving blood from a transfusion prior to 1992.

Hepatitis C is diagnosed via a blood test. Usually, the first thing that is noticed is that the liver enzyme levels for ALT and AST are elevated well above normal levels. Further investigation via HCV-RNA testing identifies whether the Hepatitis C virus is in your blood or not. Other tests for HCV include qualitative viral load tests, which measure the RNA particles in your blood. If you are being treated for HCV, your doctor is probably using either a HCV-RNA or viral load test to determine the effectiveness of the treatment.

The symptoms of Hepatitis C infection often do not occur in a person until 20 years after he/she had been infected. Since the HCV infects the liver and the liver is the organ in the body that makes all the energy for our daily activities possible, liver function deterioration often results in fatigue. Fatigue is the primary complaint or symptom of HCV infection. Other more severe symptoms are jaundice (yellowing of the skin/eyes), bile retention (which can cause jaundice), portal vein hypertension, skin rashes and itching, and autoimmune problems resulting from your body's immune system attacking normal cells.

Long term HCV infection may result in fibrosis or even cirrhosis of the liver. Fibrosis results from unchecked liver inflammation. As the HCV infection progresses, the damage to the liver results in scarring or hardening of the liver cells (fibrosis). Long term fibrosis may lead to cirrhosis which is when the scarring from fibrosis overtakes the normal liver cell structure causing deformity and loss of function in the liver. About 15%-20% of HCV patients end up with cirrhosis. A liver biopsy is currently the most accurate means of determining the amount of inflammation and fibrosis the liver has sustained.

Hepatitis C progression in the body can take several years or even decades to come to chronic stage or to a stage where severe liver damage is evident. This period of time allows a person to determine how to properly treat the disease and to decide on a course of disease management. Currently, the main treatment for HCV infection to eradicate the virus is combo alpha-interferon and Ribavirin. Sometimes a doctor may prescribe interferon alone. Interferon comes in standard form or in pegylated form. Standard form interferon is administered 3 times per week, while the pegylated form is administered only once per week. Your body makes its own interferon, which is a protein that fights viral infection and viral replication.

Hepatitis C may often be managed by taking herbal and vitamin supplements that help your body fight infection and limit inflammation. These supplements help your liver with the inflammation and give it the nutrients it needs to regenerate healthy new cells. Your doctor can recommend alternative or adjunct solutions you may want to try.

Proper treatment of the disease, a healthy and active lifestyle, a good diet, abstinence from alcohol and stress management are important factors in controlling Hepatitis C progression.

About the Author

Greg Lietz is a freelance writer and internet businessman. His main website is http://www.theonlinebizplace.com where he provides content about internet based business opportunities and different niche interests. This article may be freely printed when the bio information is included.

Hepatitis C - Ways You Can Get Infected With Hepatitis C(NC)-Hepatitis C is

Ways You Can Get Infected With Hepatitis C

(NC)-Hepatitis C is spread through contact with infected blood. Here are just some of the ways in which you can be infected with this virus:

Sharing needles, straws, pipes, spoons and other drug-related equipment.

(At least two-thirds of all new hepatitis C infections are drug-use related. Cleaning equipment with bleach does not always effectively kill the virus) p>

Getting a tattoo, body piercing or acupuncture from an operator who does not use sterile equipment or techniques

Being born to a mother with hepatitis C

Getting pierced by a needle or sharp equipment that has infected blood on it ( in a hospital, workplace situation, etc.) p>

People who had blood transfusions before the testing of blood donations became mandatory in 1990 may also be at risk. And, while the risk is low, it is also possible to become infected by sharing personal household articles such as a razor or toothbrush with an infected person. The risk of transmission of hepatitis C during sex is also low, unless both parties have open bleeding sores.

It is estimated that 240, 000 people in Canada are currently infected with hepatitis C, of whom only 30% know they have the virus.

If you think you may be at risk, either now or from past risky activities see a doctor. The virus can be detected with a simple blood test, and there are steps and medications you can take to successfully minimize the effects of the disease if your diagnosis is positive. For more information, visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.

Hepatitis C - HCV

HCV
listed below to view the PDF or click here for PDF download instructions or FAQ's on PDF issues . HCV/Clinical: Predicting sustained virological responses in chronic hepatitis C patients treated with

HCV Wireless
HCV Wireless Consulting, Systems Integration and Support Services The primary goal for HCV Wireless Professional Services is to support organisations to rapidly and effectively integrate wireless

Hepatitis C Resources and Information
Resources and Information is a website with up-to-date hepatitis C weblinks, hep C information, HCV defined and undefined, inspiration for people who have hepatitis C and their families and so much

Hepatitis C - Vaccination Tames Hepatitis A Infection

Vaccination Tames Hepatitis A Infection
Title: Vaccination Tames Hepatitis A Infection
Category: Health News
Created: 7/13/2005 1:58:00 AM
Last Editorial Review: 7/13/2005 1:58:14 AM
HCV Vaccine Progress
The development of a HCV vaccine is very exciting, even to patients already infected. Although the vaccine will not help them direcly, it shows definite progress in understanding and outsmarting this virus that is know to be hard to fight...
Fatty Liver
Title: Fatty Liver
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 8/29/2005
For Want of Six Cents
Blink: Hepatitis C Bio, Pics, News and Views from BlinkBits
Subject: For Want of Six Cents
Added by glog on Nov 26, 2005 5:21 pm (GMT -4)

Twenty-one million people each year get hepatitis B this way, two million get hepatitis C and 650000 get infected with HIV. As third-world health problems go, this one seems solvable. Single-use syringes, whose plungers break or are ...... Read more...

Visit The Harry Potter Blink
How to Choose a Doctor
Title: How to Choose a Doctor
Category: Doctor's Views
Created: 6/17/2005
Last Editorial Review: 8/9/2005

Hepatitis C - New Russian Formula for Treatment of Hepatitis C and Hepatitis B

New Russian Formula for Treatment of Hepatitis C and Hepatitis B
PR.com - Russia for the treatment of acute and chronic viral hepatitis C and hepatitis B, is is NOW available treatment of acute and chronic viral hepatitis C and hepatitis B, is

Hepatitis C - Treating Chronic Mutational Hepatitis B with Chinese Medicine Vitalliver (Vigconic

Treating Chronic Mutational Hepatitis B with Chinese Medicine Vitalliver (Vigconic Suppositories)

Treating chronic mutational hepatitis B with Chinese medicine Vitalliver (Vigconic suppositories)

ZHANG GUAN HUA, LIANG CHAO, ZHENG WAN PIN

Chengdu University of TCM, Hepatitis Laboratory in the attached hospital of Chengdu University of TCM, Sichuan, China

Research Method:

Quantitative determination by contrasting HBV-DNA of cases before and after the treatment.

Number of cases: 25 (n)

Case Selection: Between the age of 16 and 65, in accordance with the diagnosis standards pf chronic Hepatitis B, with negative e antigen and positive e antibody, HBV-DNA > 1 104 cp/mL.

Detection Method: All the blood samples are detected by Sichuan Clinical Detection Center; PCR-ELISA quantitative determination is used within detection range of 1 104 - 1 107-8, HBV-DNA, unit of measurement is cp/mL.

Direction Plan: one suppository provided by Vigconic (International) Ltd. Bid. The course of treatment is six months, the tracing observation after withdrawal lasts six months.

Observation index:

1. HBV-DNA response after the treatment.
   

2. Lasting HBV-DNA response (six months after withdrawal).
   p>

Criterion of Therapeutic Effect:

1. If HBV-DNA volume 1 104 cp/mL: 4/25 (16%)
   

2. Lasting response:
   

HBV-DNA volume 1 104 cp/mL: 2/25 (8%)

Among the results of lasting response, 16 blood serum samples are detected through fluorimetric quantitative determination PCR by the instruments of PE.USD, H-7700 in the second attached hospital of Guangzhou Medical College. The result is in accordance with that in Sichuan Clinical Testing Center. (8 cases among it 1 102 cp/mL). The testing range of this testing method is 1 102 - 1 107-8 cp/mL.

Conclusion

The reason for the repeatedly abnormal liver function of Chronic Hepatitis B (CHB) patients lies in the repeatedly duplication of HBV after infection, which leads to fibrosis of liver, then cirrhosis and liver cancer. It is commonly accepted that if CHB shows the transformation of HBeAg/Anti-HBe, HBV-DNA becoming negative, liver function returning to normal state, the disease is relieved. However, parts of patients with the transformation of HBeAg/Anti-HBe still remain positive in HBV-DNA and the pathological change in the liver continues. Because HBV-DNA occurs promoter mutation in the anterior C section (1896 necleoside G-A variation) or in the C section (1762 nucleoside T variation, 1764 G-A variation), HBeAg cannot come into being. Therefore, the HBeAg in the patient s blood cannot be detected, while the virus can keep on duplicating and fixing itself. Through sequential assay of nucleic acid, it proves that promoter mutation appears in 30%-60% of HBeAg negative Chronic Hepatitis B (CHB) in the anterior C section or in the C section. In some provinces and cities of the People of China, the percentage of promoter mutation appears in HBeAg negative Chronic Hepatitis B (CHB) in the anterior C section or in the C section is from 17.6% to 78.9%. Eight out of the 25 cases of our observation go through the sequential assay of nucleic acid carried out by the Department of Microbiology of the University of Hong Kong. It all proves to have HBV-DNA mutation. The chronic mutational Hepatitis B is infectious and apt to cause cirrhosis and liver cancer since the present medicines of antivirus and immuno-modulator do not produce the expected therapeutic effects.

Vitalliver suppository is made up from a formula of Chinese herbs, including Ginseng, Deer Horn, Cordyceps, Radix Astragali, Frudctus Cnidii, Semen Cuscutae, etc. The formula is mainly for strengthening the body resistant and primarily for reinforcing Kidney Qi, which produces good therapeutic effects in treating chronic mutational Hepatitis B. The mechanism is probably that through the regulating of immune system, the duplication of virus is inhibited and meanwhile the liver is protected, so it can produce a lasting therapeutic effect. No adverse reaction and severe accident happens during clinical observation, so it is safe for using. Vitalliver is bringing hopes to the treatment of chronic mutational Hepatitis B.

* The second stage of clinical trial would be carrying out by the Microbiology Department of the University of Hong Kong and Chengdu University of Traditional Chinese Medicine.

For more information, please visit: http://www.vigconic.com

Or, contact:

William Yip cs@vigconic.com
p>
5/F, Cheung Wah Building, Sheung Heung Rd,

Kowloon, Hong Kong

Tel: 852-27656200

Fax: 852-27645314
p>

Chengdu University of TCM, Hepatitis Laboratory in the attached hospital of Chengdu University of TCM, Sichuan, China

webmaster@vigconic.com

Hepatitis C - Hepatitis C Virus Lives In Your Liver(NC)-Your liver works 24

Hepatitis C Virus Lives In Your Liver

(NC)-Your liver works 24 hours a day, performing over 500 vital functions for your body. Most of the blood that returns to your heart passes through the liver. Your body can't function without it.

The hepatitis C virus lives in your liver. It inflames liver cells, which, over time, affects the way your liver functions. The effect of the hepatitis C virus varies from person to person. There is no way to predict how your body will react to it. There are, however, some things that are known:

You can live with hepatitis C for many years without experiencing any major symptoms, or you might simply feel tired. Symptoms can come and go over time. Their presence or absence does not tell you the degree to which liver damage may or may not be occurring. p>

Chronic, long-term inflammation of the liver can cause liver cell damage and result in fibrosis (liver scarring), or even cirrhosis. This damage can occur in as little as five years, or as long as 30 years.

About 20% of chronic hepatitis patients develop cirrhosis within 10 to 20 years.

Use of recreational drugs or alcohol can speed up inflammation and the development of fibrosis or cirrhosis.

There is an increased risk of liver cancer in people with cirrhosis.

The good news is that current drug treatments can be very effective for people with hepatitis C. Combined with proper nutrition, plenty of rest, and avoidance of recreational drugs and alcohol, these treatments help many who have the virus lead relatively healthy lives.

If you think you may be at risk of getting hepatitis C, see your doctor. The virus can be detected by a simple blood test. For more information on how to keep your liver happy and healthy, visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

p>

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services. p>

Hepatitis C - antibuse & hep C- Substance Abuse

antibuse & hep C- Substance Abuse
antibuse & hep C-Substance Abuse. Visit SoberRecovery.com Alcoholism & Addictions help forum to discuss antibuse & hep C

Depression Common with Hep C Treatment
The majority of hepatitis C patients developed at least some depressive symptoms and 33% met the criteria for major depression during interferon treatment.

Delaware County Hep C Connect
Hepatitis Patient Sees Need, Forms Popular Support Group ... Donna Cowan founded the group "Delco Hep C Connect" in Aston, Pennsylvania last fall ... Thank you all who supported Delco Hep C Connect and the 2nd annual liver awareness ride ...